You are here

Pfizer Launches ATLAS at 27th ECCMID Congress

Pfizer Launches Antimicrobial Testing Leadership and Surveillance (ATLAS) Resources at 27th ECCMID Congress

At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria, Pfizer introduced the Antimicrobial Testing Leadership and Surveillance (ATLAS) website, designed to provide physicians and the global health community with easy access to 13 years of global antimicrobial surveillance data from over 60 countries.   ATLAS can provide critical information to aid physicians in selecting the most appropriate treatment choices for their patients, can support hospitals by informing stewardship programs, and enable global health authorities to develop data-driven antimicrobial resistance mitigation strategies.  ATLAS is also available as an App to enable point of care analysis of resistance trends.   To learn more about the website for healthcare professionals, visit www.atlas-surveillance.com, or to access the App, go to the App Store and search for ‘Pfizer ATLAS.’